TRF2 Inhibits a Cell-Extrinsic Pathway Through Which Natural Killer Cells Eliminate Cancer Cells
Annamaria Biroccio,Julien Cherfils-Vicini,Adeline Augereau,Sébastien Pinte,Serge Bauwens,Jing Ye,Thomas Simonet,Béatrice Horard,Karine Jamet,Ludovic Cervera,Aaron Mendez-Bermudez,Delphine Poncet,Renée Grataroli,Claire T’kint de Rodenbeeke,Erica Salvati,Angela Rizzo,Pasquale Zizza,Michelle Ricoul,Céline Cognet,Thomas Kuilman,Helene Duret,Florian Lépinasse,Jacqueline Marvel,Els Verhoeyen,François-Loïc Cosset,Daniel Peeper,Mark J. Smyth,Arturo Londoño-Vallejo,Laure Sabatier,Vincent Picco,Gilles Pages,Jean-Yves Scoazec,Antonella Stoppacciaro,Carlo Leonetti,Eric Vivier,Eric Gilson
DOI: https://doi.org/10.1038/ncb2774
IF: 21.3
2013-01-01
Nature Cell Biology
Abstract:Dysfunctional telomeres suppress tumour progression by activating cell-intrinsic programs that lead to growth arrest. Increased levels of TRF2, a key factor in telomere protection, are observed in various human malignancies and contribute to oncogenesis. We demonstrate here that a high level of TRF2 in tumour cells decreased their ability to recruit and activate natural killer (NK) cells. Conversely, a reduced dose of TRF2 enabled tumour cells to be more easily eliminated by NK cells. Consistent with these results, a progressive upregulation of TRF2 correlated with decreased NK cell density during the early development of human colon cancer. By screening for TRF2-bound genes, we found that HS3ST4 —a gene encoding for the heparan sulphate (glucosamine) 3- O -sulphotransferase 4—was regulated by TRF2 and inhibited the recruitment of NK cells in an epistatic relationship with TRF2. Overall, these results reveal a TRF2-dependent pathway that is tumour-cell extrinsic and regulates NK cell immunity.